The previous study also reported reduced risk of ER-positive (OR = 0.91, 95% CI: 0.82, 1.01) and increased risk of ER-negative (OR = 1.14, 95% CI: 1.01, 1.28) breast cancer per SD increase in SHBG. This evidence concerns the gene SHBG and breast carcinoma.